Ferring Pharmaceuticals Inc. et al v. Novel Laboratories, Inc. et al
| Ferring Pharmaceuticals Inc., Ferring International Center S.A. and Ferring B.V. |
| Novel Laboratories, Inc. and Gavis Pharmaceuticals, LLC |
| Novel Laboratories, Inc. and Gavis Pharmaceuticals, LLC |
| Ferring International Center S.A. and Ferring Pharmaceuticals Inc. |
| 1:2017cv00894 |
| July 5, 2017 |
| U.S. District Court for the District of Delaware |
| Wilmington Office |
| New Castle |
| Richard G. Andrews |
| Patent - Abbreviated New Drug Application |
| 35 U.S.C. ยง 271 |
| None |
Available Case Documents
The following documents for this case are available for you to view or download:
| Document Text |
|---|
Filing
119
MEMORANDUM. Signed by Judge Richard G. Andrews on 10/18/2018. (nms)
|
Filing
59
REPORT AND RECOMMENDATIONS re 16 MOTION for Judgment on the Pleadings Under Fed. R. Civ. P. 12(c) for Lack of Subject Matter Jurisdiction filed by Gavis Pharmaceuticals, LLC, Novel Laboratories, Inc. Please note that when filing Objections pursuant to Federal Rule of Civil Procedure 72(b)(2), briefing consists solely of the Objections (no longer than ten (10) pages) and the Response to the Objections (no longer than ten (10) pages). No further briefing shall be permitted with respect to objections without leave of the Court. Objections to R&R due by 4/16/2018. Signed by Judge Mary Pat Thynge on 4/2/18. (cak)
|
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.